PGEN Precigen Inc

Price (delayed)

$1.365

Market cap

$339.77M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.39

Enterprise value

$339.29M

Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases ...

Highlights
PGEN's quick ratio has soared by 94% YoY and by 4.9% from the previous quarter
Precigen's debt has plunged by 86% YoY and by 4% from the previous quarter
PGEN's gross profit has dropped by 99% year-on-year and by 86% since the previous quarter
PGEN's gross margin has plunged by 98% YoY and by 85% from the previous quarter

Key stats

What are the main financial stats of PGEN
Market
Shares outstanding
248.92M
Market cap
$339.77M
Enterprise value
$339.29M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.87
Price to sales (P/S)
53.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
54.5
Earnings
Revenue
$6.23M
EBIT
-$95.89M
EBITDA
-$89.23M
Free cash flow
-$68.37M
Per share
EPS
-$0.39
Free cash flow per share
-$0.28
Book value per share
$0.48
Revenue per share
$0.03
TBVPS
$0.34
Balance sheet
Total assets
$151.04M
Total liabilities
$32.55M
Debt
$7.1M
Equity
$118.5M
Working capital
$45.77M
Liquidity
Debt to equity
0.06
Current ratio
2.99
Quick ratio
2.8
Net debt/EBITDA
0.01
Margins
EBITDA margin
-1,433.3%
Gross margin
1.7%
Net margin
-1,540.6%
Operating margin
-1,602.5%
Efficiency
Return on assets
-48.5%
Return on equity
-62.2%
Return on invested capital
-113.2%
Return on capital employed
-74.9%
Return on sales
-1,540.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PGEN stock price

How has the Precigen stock price performed over time
Intraday
2.63%
1 week
-2.5%
1 month
-2.15%
1 year
11.89%
YTD
1.87%
QTD
-5.86%

Financial performance

How have Precigen's revenue and profit performed over time
Revenue
$6.23M
Gross profit
$106,000
Operating income
-$99.76M
Net income
-$95.9M
Gross margin
1.7%
Net margin
-1,540.6%
PGEN's gross profit has dropped by 99% year-on-year and by 86% since the previous quarter
PGEN's gross margin has plunged by 98% YoY and by 85% from the previous quarter
Precigen's revenue has plunged by 77% YoY and by 8% from the previous quarter
Precigen's operating income has decreased by 32% YoY and by 14% from the previous quarter

Growth

What is Precigen's growth rate over time

Valuation

What is Precigen stock price valuation
P/E
N/A
P/B
2.87
P/S
53.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
54.5
Precigen's EPS has decreased by 5% QoQ
PGEN's P/B is 62% below its 5-year quarterly average of 7.4 but 33% above its last 4 quarters average of 2.1
PGEN's equity is down by 20% since the previous quarter and by 6% year-on-year
PGEN's P/S is 96% below its 5-year quarterly average of 1309.5 but 63% above its last 4 quarters average of 32.1
Precigen's revenue has plunged by 77% YoY and by 8% from the previous quarter

Efficiency

How efficient is Precigen business performance
Precigen's return on sales has decreased by 24% QoQ
The ROA has contracted by 22% from the previous quarter
The ROIC has contracted by 14% from the previous quarter
PGEN's return on equity is down by 14% since the previous quarter

Dividends

What is PGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGEN.

Financial health

How did Precigen financials performed over time
PGEN's current ratio has surged by 99% year-on-year and by 6% since the previous quarter
PGEN's quick ratio has soared by 94% YoY and by 4.9% from the previous quarter
Precigen's debt is 94% less than its equity
Precigen's debt has plunged by 86% YoY and by 4% from the previous quarter
PGEN's debt to equity has plunged by 85% YoY but it is up by 20% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.